NEW YORK (TheStreet) -- CHANGE IN RATINGS
Agilent was downgraded at Goldman Sachs to neutral. $47 price target. Company lacks near-term catalysts, Goldman said.
Allergan was downgraded at Wells Fargo to market perform. Restasis will likely soon face generic competition, Wells Fargo said.
Bunge was downgraded to hold at TheStreet Ratings.
Coach was downgraded at Lazard Capital Markets to neutral from buy. Company could face increased competition, Lazard Capital Markets said.
Diana Containerships was downgraded to sell at TheStreet Ratings.
Newell Rubbermaid was initiated with a neutral rating at Goldman Sachs. $27 price target. Valuation call, as the stock is up 70% from its 2011 lows, Goldman said.
Waters was upgraded at Goldman Sachs to buy. $120 price target. Company is seeing better end-market demand, Goldman said.
STOCK COMMENTS/EPS CHANGES
Apple estimates, price target were cut at Oppenheimer. Shares are now seen reaching $460. Estimates were reduced, given slower iPhone demand, Oppenheimer said. Outperform rating.
Amazon estimates were reduced at UBS. AMZN 2014 earnings estimates were cut given moderating sales trends in the retail business, said UBS.
Blackberry numbers were reduced at Citigroup. Earnings estimates were reduced as competition affects demand, said Citi. Price target is $10.
Freeport McMoRan earnings estimates were adjusted at UBS to reflect production losses at Grasberg and a new oil and gas outlook, UBS said.
Inergy numbers were cut at UBS to reflect the dilution related to the CMLP deal, said UBS. Price target was reduced to $16.
>To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.
EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.
- Investment & Company Information
- Goldman Sachs
- Lazard Capital Markets
- Wells Fargo